Patents by Inventor Martin Boyer
Martin Boyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12245948Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.Type: GrantFiled: July 12, 2022Date of Patent: March 11, 2025Assignee: ExsoMed CorporationInventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
-
Publication number: 20230200876Abstract: A four corner fusion system can include a curved plate that is more aligned with the natural anatomy of the wrist joint, and/or fewer number of screws (for example, about three or four screws). The system can have a lower profile, resulting in less soft tissue impingement. A surgical tool with a pair of offsetting clamping arms can be used to aid in bone reduction during a wrist fusion procedure.Type: ApplicationFiled: April 30, 2021Publication date: June 29, 2023Inventors: Martin Boyer, Kathleen McKeon, Kavi Sachar, Andrew J. Leither, Michael Zwolinski
-
Publication number: 20230063432Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.Type: ApplicationFiled: July 12, 2022Publication date: March 2, 2023Inventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
-
Patent number: 11413155Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.Type: GrantFiled: April 10, 2019Date of Patent: August 16, 2022Assignee: Exsomed CorporationInventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
-
Publication number: 20190307570Abstract: The present invention relates to a crescent or tri-corner shaped orthopedic plate with at least a first and a second end, and generally coextensive top and bottom surfaces joined directly or indirectly by an edge. The plate includes a plurality of fixation holes the first end of the plate and a second end of the plate that receives locking screws and intermediate the two holes, the plate includes a recess that defines a screw hole edge at an angle relative to the top surface of the plate so as to receive and support a screw in the recess. The invention further relates to a method of fusion using the plate and a clamp designed for the method.Type: ApplicationFiled: April 10, 2019Publication date: October 10, 2019Inventors: Martin Boyer, Andrew Leither, Kathleen McKeon, Kulvinder Sachar, Michael Zwolinski
-
Patent number: 8580262Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.Type: GrantFiled: July 16, 2012Date of Patent: November 12, 2013Assignee: ID Biomedical Corporation of QuebecInventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
-
Publication number: 20130095498Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.Type: ApplicationFiled: July 16, 2012Publication date: April 18, 2013Applicant: ID BIOMEDICAL CORPORATION OF QUEBECInventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
-
Patent number: 8309096Abstract: Fusion proteins comprising an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1, which may further comprise carriers, fusion partners, or the like, are provided. Methods for preparing, formulating, and using such fusion proteins are also provided. Such proteins are useful a vaccine components for inducing an immune response against a range of cancer-antigen-bearing cells.Type: GrantFiled: July 15, 2009Date of Patent: November 13, 2012Assignee: GlaxoSmithKline Biologicals S.A.Inventors: Normand Blais, Martine Boyer, Vincent Brichard, Jamila Louahed, Denis Martin, Remi Palmantier, Clement Rioux
-
Patent number: 8226953Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.Type: GrantFiled: December 28, 2010Date of Patent: July 24, 2012Assignee: ID Biomedical Corporation of QuebecInventors: Bernard R. Brodeur, Clement Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
-
Publication number: 20110182923Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.Type: ApplicationFiled: December 28, 2010Publication date: July 28, 2011Applicant: ID BIOMEDICAL CORPORATIONInventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
-
Patent number: 7914794Abstract: Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.Type: GrantFiled: January 13, 2003Date of Patent: March 29, 2011Assignee: ID Biomedical CorporationInventors: Bernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
-
Patent number: 7811585Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.Type: GrantFiled: July 9, 2007Date of Patent: October 12, 2010Assignee: ID Biomedical CorporationInventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
-
Patent number: 7740870Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.Type: GrantFiled: June 9, 2008Date of Patent: June 22, 2010Assignee: ID Biomedical CorporationInventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
-
Publication number: 20100029912Abstract: Fusion proteins comprising an antigen derived from NY-ESO-1 linked to an antigen derived from LAGE-1, which may further comprise carriers, fusion partners, or the like, are provided. Methods for preparing, formulating, and using such fusion proteins are also provided. Such proteins are useful a vaccine components for inducing an immune response against a range of cancer-antigen-bearing cells.Type: ApplicationFiled: July 15, 2009Publication date: February 4, 2010Applicant: GlaxoSmithKline Biologicals SAInventors: Normand Blais, Martine Boyer, Vincent Brichard, Jamila Louahed, Denis Martin, Remi Palmantier, Clement Rioux
-
Publication number: 20090042794Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.Type: ApplicationFiled: June 9, 2008Publication date: February 12, 2009Applicant: ID BIOMEDICAL CORPORATIONInventors: Denis Martin, Stephane Rioux, Bernard R. Brodeur, Josee Hamel, Martine Boyer
-
Publication number: 20080227706Abstract: Group B Streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.Type: ApplicationFiled: January 22, 2008Publication date: September 18, 2008Applicant: ID BIOMEDICAL CORPORATIONInventors: Denis Martin, Stephane Rioux, Martine Boyer, Josee Hamel, Bernard R. Brodeur
-
Patent number: 7393536Abstract: The present invention relates to antigens, more particularly antigens of Group B Streptococcus (GBS) (S. agalactiae) which may be useful to prevent, diagnose and/or treat streptococcal infections.Type: GrantFiled: July 5, 2002Date of Patent: July 1, 2008Assignee: ID Biomedical CorporationInventors: Denis Martin, Stéphane Rioux, Bernard R. Brodeur, Josée Hamel, Martine Boyer
-
Patent number: 7335368Abstract: Group B streptococcus polypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.Type: GrantFiled: October 15, 2001Date of Patent: February 26, 2008Assignee: ID Biomedical CorporationInventors: Denis Martin, Stephane Rioux, Martine Boyer, Josée Hamel, Bernard R Brodeur
-
Publication number: 20080038268Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.Type: ApplicationFiled: July 9, 2007Publication date: February 14, 2008Applicant: ID Biomedical CorporationInventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
-
Patent number: 7247308Abstract: The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.Type: GrantFiled: July 6, 2001Date of Patent: July 24, 2007Assignee: ID Biomedical CorporationInventors: Denis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer